New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies…
December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics,…
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing…
In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients…
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers.The application combines advanced BioLizard’s bioinformatics expertise…
Synchronizing sales and marketing improves outcomes, yet 65% of field engagements are not SINGAPORE, Dec. 5, 2024 /PRNewswire/ -- Veeva…
Cribl Achieves Security Lake Service Ready Specialization and Migration & Modernization Competency; Introduces Powerful New AWS Service Integrations December 04,…
PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially joined the Luxurynsight Group. This strategic operation marks…
PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially joined the Luxurynsight Group. This strategic operation marks…
PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially joined the Luxurynsight Group. This strategic operation marks…
